253 related articles for article (PubMed ID: 15622502)
1. Renal tubular dysfunction in children with systemic lupus erythematosus.
Marks SD; Shah V; Pilkington C; Woo P; Dillon MJ
Pediatr Nephrol; 2005 Feb; 20(2):141-8. PubMed ID: 15622502
[TBL] [Abstract][Full Text] [Related]
2. The dynamics of urinary N-acetyl-β-D-glucosaminidase (NAG), a marker of renal tubular dysfunction, in patients with lupus nephritis undergoing oral prednisone therapy.
Gluhovschi C; Velciov S; Kaycsa A; Gluhovschi G; Petrica L; Marian R; Bozdog G; Gadalean F; Bob F; Cioca D; Vernic C
Immunopharmacol Immunotoxicol; 2012 Feb; 34(1):163-9. PubMed ID: 21651460
[TBL] [Abstract][Full Text] [Related]
3. Assessment of lupus nephritis activity using urinary retinol-binding protein.
Sesso R; Rettori R; Nishida S; Sato E; Ajzen H; Pereira AB
Nephrol Dial Transplant; 1994; 9(4):367-71. PubMed ID: 8084448
[TBL] [Abstract][Full Text] [Related]
4. Glomerular filtration rate and urinary albumin excretion rate in systemic lupus erythematosus.
Cottiero RA; Madaio MP; Levey AS
Nephron; 1995; 69(2):140-6. PubMed ID: 7723895
[TBL] [Abstract][Full Text] [Related]
5. Angiopoietin-2, endothelial dysfunction and renal involvement in patients with systemic lupus erythematosus.
El-Banawy HS; Gaber EW; Maharem DA; Matrawy KA
J Nephrol; 2012; 25(4):541-50. PubMed ID: 21956768
[TBL] [Abstract][Full Text] [Related]
6. Urinary N-acetyl-beta-D-glucosaminidase (NAG) in lupus nephritis and rheumatoid arthritis.
Erdener D; Aksu K; Biçer I; Doğanavşargil E; Kutay FZ
J Clin Lab Anal; 2005; 19(4):172-6. PubMed ID: 16025478
[TBL] [Abstract][Full Text] [Related]
7. Histological antiphospholipid-associated nephropathy versus lupus nephritis in patients with systemic lupus erythematosus: an observational cross-sectional study with longitudinal follow-up.
Gerhardsson J; Sundelin B; Zickert A; Padyukov L; Svenungsson E; Gunnarsson I
Arthritis Res Ther; 2015 Apr; 17(1):109. PubMed ID: 25927214
[TBL] [Abstract][Full Text] [Related]
8. Urinary neutrophil gelatinase-associated lipocalin as a biomarker of nephritis in childhood-onset systemic lupus erythematosus.
Brunner HI; Mueller M; Rutherford C; Passo MH; Witte D; Grom A; Mishra J; Devarajan P
Arthritis Rheum; 2006 Aug; 54(8):2577-84. PubMed ID: 16868980
[TBL] [Abstract][Full Text] [Related]
9. The outcome of patients with renal involvement in pediatric-onset systemic lupus erythematosus--a 20-year experience in Asia.
Lee PY; Yeh KW; Yao TC; Lee WI; Lin YJ; Huang JL
Lupus; 2013 Dec; 22(14):1534-40. PubMed ID: 23966304
[TBL] [Abstract][Full Text] [Related]
10. The use of the British Isles Lupus Assessment Group (BILAG) index as a valid tool in assessing disease activity in childhood-onset systemic lupus erythematosus.
Marks SD; Pilkington C; Woo P; Dillon MJ
Rheumatology (Oxford); 2004 Sep; 43(9):1186-9. PubMed ID: 15226518
[TBL] [Abstract][Full Text] [Related]
11. Assessment of premature atherosclerosis in systemic lupus erythematosus patients with and without nephritis.
Sharma SK; Rathi M; Sahoo S; Prakash M; Dhir V; Singh S
Lupus; 2016 Apr; 25(5):525-31. PubMed ID: 26678442
[TBL] [Abstract][Full Text] [Related]
12. The serum levels of connective tissue growth factor in patients with systemic lupus erythematosus and lupus nephritis.
Wang FM; Yu F; Tan Y; Liu G; Zhao MH
Lupus; 2014 Jun; 23(7):655-64. PubMed ID: 24536044
[TBL] [Abstract][Full Text] [Related]
13. Measurement of interleukin-1 receptor antagonist in patients with systemic lupus erythematosus could predict renal manifestation of the disease.
Brugos B; Kiss E; Dul C; Gubisch W; Szegedi G; Sipka S; Zeher M
Hum Immunol; 2010 Sep; 71(9):874-7. PubMed ID: 20538031
[TBL] [Abstract][Full Text] [Related]
14. Decreased serum levels of TGF-β1 are associated with renal damage in female patients with systemic lupus erythematosus.
Jin T; Almehed K; Carlsten H; Forsblad-d'Elia H
Lupus; 2012 Mar; 21(3):310-8. PubMed ID: 22072025
[TBL] [Abstract][Full Text] [Related]
15. Glomerular c4d staining can be an indicator of disease activity in lupus nephritis.
Sahin OZ; Gurses S; Taslı F; Yavas H; Ersoy R; Uzum A; Cirit M
Ren Fail; 2013; 35(2):222-5. PubMed ID: 23176021
[TBL] [Abstract][Full Text] [Related]
16. Urine osteoprotegerin and monocyte chemoattractant protein-1 in lupus nephritis.
Kiani AN; Johnson K; Chen C; Diehl E; Hu H; Vasudevan G; Singh S; Magder LS; Knechtle SJ; Petri M
J Rheumatol; 2009 Oct; 36(10):2224-30. PubMed ID: 19648301
[TBL] [Abstract][Full Text] [Related]
17. Urinary excretion of albumin and retinol binding protein in systemic lupus erythematosus.
Guy JM; Brammah TB; Holt L; Bernstein RM; McMurray JR; Tieszen K; Cooper RG
Ann Clin Biochem; 1997 Nov; 34 ( Pt 6)():668-74. PubMed ID: 9367006
[TBL] [Abstract][Full Text] [Related]
18. Plasma-soluble urokinase-type plasminogen activator receptor levels are associated with clinical and pathological activities in lupus nephritis: a large cohort study from China.
Qin DD; Song D; Huang J; Yu F; Zhao MH
Lupus; 2015 May; 24(6):546-57. PubMed ID: 25411257
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor beta 1 in children with systemic lupus erythematosus: a possible relation with clinical presentation of lupus nephritis.
Hammad AM; Youssef HM; El-Arman MM
Lupus; 2006; 15(9):608-12. PubMed ID: 17080918
[TBL] [Abstract][Full Text] [Related]
20. N-Acetyl-Seryl-Aspartyl-Lysyl-Proline: mechanisms of renal protection in mouse model of systemic lupus erythematosus.
Liao TD; Nakagawa P; Janic B; D'Ambrosio M; Worou ME; Peterson EL; Rhaleb NE; Yang XP; Carretero OA
Am J Physiol Renal Physiol; 2015 May; 308(10):F1146-54. PubMed ID: 25740596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
